Drug-gene interactions of antihypertensive medications and risk of incident cardiovascular disease: A pharmacogenomics study from the CHARGE consortium
Joshua C. Bis, Colleen Sitlani, Ryan Irvin, Christy L. Avery, Albert Vernon Smith, Fangui Sun, Daniel S. Evans, Solomon K. Musani, Xiaohui Li, Stella Trompet, Bouwe P. Krijthe, Tamara B. Harris, P. Miguel Quibrera, Jennifer A. Brody, Serkalem Demissie, Barry R. Davis, Kerri L. Wiggins, Gregory J. Tranah, Leslie A. Lange, Nona SotoodehniaDavid J. Stott, Oscar H. Franco, Lenore J. Launer, Til Stürmer, Kent D. Taylor, L. Adrienne Cupples, John H. Eckfeldt, Nicholas L. Smith, Yongmei Liu, James G. Wilson, Susan R. Heckbert, Brendan M. Buckley, M. Arfan Ikram, Eric Boerwinkle, Yii Der Ida Chen, Anton J.M. De Craen, Andre G. Uitterlinden, Jerome I. Rotter, Ian Ford, Albert Hofman, Naveed Sattar, P. Eline Slagboom, Rudi G.J. Westendorp, Vilmundur Gudnason, Ramachandran S. Vasan, Thomas Lumley, Steven R. Cummings, Herman A. Taylor, Wendy Post, J. Wouter Jukema, Bruno H. Stricker, Eric A. Whitsel, Bruce M. Psaty, Donna Arnett
Dive into the research topics of 'Drug-gene interactions of antihypertensive medications and risk of incident cardiovascular disease: A pharmacogenomics study from the CHARGE consortium'. Together they form a unique fingerprint.